Explorative Exmination of Coronary Microcirculatory Ischemia in Type 2 Diabetes Mellitus Patients With One-Stop Cardiac Computed Tomography

XIONG Yijia, ZHU Wangshu, LING Runjianya, MA Jian, LI Yuehua

Abstract

Objective To analyze the differences in computed tomography (CT) myocardial perfusion parameters between type 2 diabetes mellitus (T2DM) patients and nondiabetic patients diagnosed with non-obstructive coronary artery disease (CAD), using a one-stop cardiac CT scanning protocol that combines coronary CT angiography (CCTA) with dynamic CT myocardial perfusion imaging (CT-MPI). In addition, we investigated the effect of T2DM on coronary microcirculatory ischemia.

Methods After balancing the baseline levels with propensity score matching, 92 T2DM patients (the T2DM group) and 92 nondiabetic patients (the nondiabetic group) with non-obstructive CAD were enrolled eventually. The clinical characteristics and the CCTA and CT-MPI results of the two groups were compared. A directed acyclic graph was used to analyze the causal relationships between the variables and to identify key confounding factors. A multivariable regression model was established to evaluate the independent effect of T2DM on the occurrence of coronary microcirculatory ischemia after adjusting for confounding factors.

Results There were no statistically significant differences between the T2DM group and the nondiabetic group in terms of age, sex, hypertension, hyperlipidemia, smoking history, body mass index, chest symptoms, calcium score, CAD-reporting and data system (CAD-RADS) score, and radiation dose. In the T2DM group, the mean values of myocardial blood flow (MBF) were significantly reduced both globally and in all myocardial segments (basal, mid, and apical segments) compared to those of the nondiabetic group (P<0.05). Furthermore, the incidence of coronary microcirculatory ischemia in the T2DM group was significantly higher than that in the nondiabetic group (21.7% [20/92] vs. 5.4% [5/92], P=0.01). Multivariable logistic regression analysis showed that T2DM was an important independent risk factor for coronary microcirculatory ischemia (odds ratio=5.095, 95% confidence interval: 1.753-14.805).

Conclusion According to our assessment with a one-stop cardiac CT scanning protocol combining CCTA and dynamic CT-MPI, patients with non-obstructive CAD and T2DM have reduced global MBF, which makes them more prone to coronary microcirculatory ischemia. Furthermore, T2DM is independently associated with coronary microcirculatory ischemia.

Keywords: Coronary disease, Microcirculation, Myocardial ischemia, Myocardial perfusion imaging, Type 2 diabetes mellitus


Full Text:

PDF


References


KHUNTI K, CHUDASAMA Y V, GREGG E W, et al. Diabetes and multiple long-term conditions: a review of our current global health challenge. Diabetes Care, 2023, 46(12): 2092-2101. doi: 10.2337/dci23-0035.

AHMAD E, LIM S, LAMPTEY R, et al. Type 2 diabetes. Lancet, 2022, 400(10365): 1803-1820. doi: 10.1016/S0140-6736(22)01655-5.

BOLATAI A, HE Y, WU N. Vascular endothelial growth factor and its receptors regulation in gestational diabetes mellitus and eclampsia. J Transl Med, 2022, 20(1): 400. doi: 10.1186/s12967-022-03603-4.

CHEN S, SHEN Y, LIU Y H, et al. Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol, 2021, 20(1): 64. doi: 10.1186/s12933-021-01257-y.

ZHAO F, SATYANARAYANA G, ZHANG Z, et al. Endothelial autophagy in coronary microvascular dysfunction and cardiovascular disease. Cells, 2022, 11(13): 2081. doi: 10.3390/cells11132081.

LIU Y, ZHONG C, CHEN S, et al. Circulating exosomal miR-16-2-3p is associated with coronary microvascular dysfunction in diabetes through regulating the fatty acid degradation of endothelial cells. Cardiovasc Diabetol, 2024, 23(1): 60. doi: 10.1186/s12933-024-02142-0.

ELGENDY I Y, YA'QOUB L, CHEN K H, et al. Coronary microvascular dysfunction in patients with non-obstructive coronary arteries: current gaps and future directions. Drugs, 2022, 82(3): 241-250. doi: 10.1007/s40265-021-01667-y.

DODD J D, LEIPSIC J A. Evolving developments in cardiac CT. Radiology, 2023, 307(3): e222827. doi: 10.1148/radiol.222827.

BUDOFF M J, KINNINGER A, GRANSAR H, et al. When does a calcium score equate to secondary prevention? Insights From the multinational CONFIRM registry. JACC Cardiovasc Imaging, 2023, 16(9): 1181-1189. doi: 10.1016/j.jcmg.2023.03.008.

HAASE R, SCHLATTMANN P, GUERET P, et al. Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data. BMJ, 2019, 365: l1945. doi: 10.1136/bmj.l1945.

LI Y, YU M, DAI X, et al. Detection of hemodynamically significant coronary stenosis: CT myocardial perfusion versus machine learning CT fractional flow reserve. Radiology, 2019, 293(2): 305-314. doi: 10.1148/radiol.2019190098.

GRANDHI G R, BATLLE J C, MAROULES C D, et al. Combined stress myocardial CT perfusion and coronary CT angiography as a feasible strategy among patients presenting with acute chest pain to the emergency department. J Cardiovasc Comput Tomogr, 2021, 15(2): 129-136. doi: 10.1016/j.jcct.2020.06.195.

ELSAYED N A, ALEPPO G, ARODA V R, et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care, 2023, 46(Suppl 1): S19-S40. doi: 10.2337/dc23-S002.

CERQUEIRA M D, WEISSMAN N J, DILSIZIAN V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation, 2002, 105(4): 539-542. doi: 10. 1161/hc0402.102975.

CURY R C, LEIPSIC J, ABBARA S, et al. CAD-RADSTM 2.0-2022 coronary artery disease-reporting and data system: an Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI). J Cardiovasc Comput Tomogr, 2022, 16(6): 536-557. doi: 10.1016/j.jcct.2022.07.002.

JIA G, BAI H, MATHER B, et al. Diabetic vasculopathy: molecular mechanisms and clinical insights. Int J Mol Sci, 2024, 25(2): 804. doi: 10. 3390/ijms25020804.

ERDOGAN D, YUCEL H, UYSAL B A, et al. Effects of prediabetes and diabetes on left ventricular and coronary microvascular functions. Metabolism, 2013, 62(8): 1123-1130. doi: 10.1016/j.metabol.2013.02.011.

SOROP O, Van De WOUW J, CHANDLER S, et al. Experimental animal models of coronary microvascular dysfunction. Cardiovasc Res, 2020, 116(4): 756-770. doi: 10.1093/cvr/cvaa002.

BAIREY M C, PEPINE C J, SHIMOKAWA H, et al. Treatment of coronary microvascular dysfunction. Cardiovasc Res, 2020, 116(4): 856- 870. doi: 10.1093/cvr/cvaa006.


Refbacks

  • There are currently no refbacks.